EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $20,070 | -17.9% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $24,450 | +3.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $23,740 | +37.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $17,220 | -2.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $17,620 | -0.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $17,685 | -17.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $21,370 | -10.2% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $23,800 | +21.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $19,670 | +11.0% | 1,000 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $17,720 | -17.7% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $21,520 | -2.8% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $22,150 | -34.0% | 1,000 | -9.4% | 0.00% | -25.0% |
| Q4 2017 | $33,562 | +25.5% | 1,104 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $26,750 | – | 1,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |